Gligorijević, Nevenka N.

Link to this page

Authority KeyName Variants
7623f71d-1181-4b76-ab3a-9d0f35017216
  • Gligorijević, Nevenka N. (2)

Author's Bibliography

Hieracium waldsteinii (Asteraceae) and Onosma stellulata (Boraginaceae) as a Source of Antioxidant and Antimicrobial Agents

Kostić, Aleksandar Ž.; Mačukanović-Jocić, Marina P.; Milinčić, Danijel D.; Petrović, Jovana D.; Gašić, Uroš M.; Gligorijević, Nevenka N.; Jarić, Snežana V.; Soković, Marina; Tešić, Živoslav Lj.; Pešić, Mirjana B.

(Wiley, 2022)

TY  - JOUR
AU  - Kostić, Aleksandar Ž.
AU  - Mačukanović-Jocić, Marina P.
AU  - Milinčić, Danijel D.
AU  - Petrović, Jovana D.
AU  - Gašić, Uroš M.
AU  - Gligorijević, Nevenka N.
AU  - Jarić, Snežana V.
AU  - Soković, Marina
AU  - Tešić, Živoslav Lj.
AU  - Pešić, Mirjana B.
PY  - 2022
UR  - http://www.ncbi.nlm.nih.gov/pubmed/35213785
UR  - http://cherry.chem.bg.ac.rs/handle/123456789/5203
AB  - The current study aimed to phytochemically characterize (including a detailed phenolic profile) two endemic Balkan's species (Hieracium waldsteinii and Onosma stellulata) and determine their possible application as a source of natural antioxidant and antimicrobial agents. The main phenolic compound in both species (in all examined parts) was chlorogenic acid. Eriodictyol, genistein and naringenin were quantified only in H. waldsteinii while isorhamnetin-3-O-rutinoside and sinapic acid were characteristic for O. stellulata. The highest antioxidant activity (98 mg AAE/g dry weight for TAC assay) was ascribed to the flower extract of H. waldsteinii while the lowest results (∼4.3 mg AAE/g dry weight for FRP assay) were exhibited by the extracts obtained from the plant's stem. Antimicrobial assays showed moderate antibacterial, i. e., moderate/strong activity against several tested fungi (in particular Trichoderma viride). Correlation analysis revealed strong positive connection between phenolic compounds and reducing power of extracts as well as between total phenolic and flavonoid content and the obtained minimal inhibitory concentration recorded in antibacterial assays.
PB  - Wiley
T2  - Chemistry and Biodiversity
T1  - Hieracium waldsteinii (Asteraceae) and Onosma stellulata (Boraginaceae) as a Source of Antioxidant and Antimicrobial Agents
VL  - 19
IS  - 4
SP  - e202200069
DO  - 10.1002/cbdv.202200069
ER  - 
@article{
author = "Kostić, Aleksandar Ž. and Mačukanović-Jocić, Marina P. and Milinčić, Danijel D. and Petrović, Jovana D. and Gašić, Uroš M. and Gligorijević, Nevenka N. and Jarić, Snežana V. and Soković, Marina and Tešić, Živoslav Lj. and Pešić, Mirjana B.",
year = "2022",
abstract = "The current study aimed to phytochemically characterize (including a detailed phenolic profile) two endemic Balkan's species (Hieracium waldsteinii and Onosma stellulata) and determine their possible application as a source of natural antioxidant and antimicrobial agents. The main phenolic compound in both species (in all examined parts) was chlorogenic acid. Eriodictyol, genistein and naringenin were quantified only in H. waldsteinii while isorhamnetin-3-O-rutinoside and sinapic acid were characteristic for O. stellulata. The highest antioxidant activity (98 mg AAE/g dry weight for TAC assay) was ascribed to the flower extract of H. waldsteinii while the lowest results (∼4.3 mg AAE/g dry weight for FRP assay) were exhibited by the extracts obtained from the plant's stem. Antimicrobial assays showed moderate antibacterial, i. e., moderate/strong activity against several tested fungi (in particular Trichoderma viride). Correlation analysis revealed strong positive connection between phenolic compounds and reducing power of extracts as well as between total phenolic and flavonoid content and the obtained minimal inhibitory concentration recorded in antibacterial assays.",
publisher = "Wiley",
journal = "Chemistry and Biodiversity",
title = "Hieracium waldsteinii (Asteraceae) and Onosma stellulata (Boraginaceae) as a Source of Antioxidant and Antimicrobial Agents",
volume = "19",
number = "4",
pages = "e202200069",
doi = "10.1002/cbdv.202200069"
}
Kostić, A. Ž., Mačukanović-Jocić, M. P., Milinčić, D. D., Petrović, J. D., Gašić, U. M., Gligorijević, N. N., Jarić, S. V., Soković, M., Tešić, Ž. Lj.,& Pešić, M. B.. (2022). Hieracium waldsteinii (Asteraceae) and Onosma stellulata (Boraginaceae) as a Source of Antioxidant and Antimicrobial Agents. in Chemistry and Biodiversity
Wiley., 19(4), e202200069.
https://doi.org/10.1002/cbdv.202200069
Kostić AŽ, Mačukanović-Jocić MP, Milinčić DD, Petrović JD, Gašić UM, Gligorijević NN, Jarić SV, Soković M, Tešić ŽL, Pešić MB. Hieracium waldsteinii (Asteraceae) and Onosma stellulata (Boraginaceae) as a Source of Antioxidant and Antimicrobial Agents. in Chemistry and Biodiversity. 2022;19(4):e202200069.
doi:10.1002/cbdv.202200069 .
Kostić, Aleksandar Ž., Mačukanović-Jocić, Marina P., Milinčić, Danijel D., Petrović, Jovana D., Gašić, Uroš M., Gligorijević, Nevenka N., Jarić, Snežana V., Soković, Marina, Tešić, Živoslav Lj., Pešić, Mirjana B., "Hieracium waldsteinii (Asteraceae) and Onosma stellulata (Boraginaceae) as a Source of Antioxidant and Antimicrobial Agents" in Chemistry and Biodiversity, 19, no. 4 (2022):e202200069,
https://doi.org/10.1002/cbdv.202200069 . .
1
6
6
3

Ispitivanje antiproliferativnog i in vitro antimetastatskog potencijala pikolinato rutenijum(II)-cimenskog kompleksa : poređenje sa serijom rutenijum(II)-arenskih kompleksa sa sličnom strukturom

Gligorijević, Nevenka N.

(Универзитет у Београду, Хемијски факултет, 2012)

TY  - THES
AU  - Gligorijević, Nevenka N.
PY  - 2012
UR  - http://eteze.bg.ac.rs/application/showtheses?thesesId=244
UR  - https://fedorabg.bg.ac.rs/fedora/get/o:5516/bdef:Content/download
UR  - http://vbs.rs/scripts/cobiss?command=DISPLAY&base=70036&RID=43575823
UR  - http://nardus.mpn.gov.rs/123456789/3462
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/2606
AB  - Cilj ove disertacije bio je ispitivanje potencijala antiproliferativnog i in vitroantimetastatskog dejstva serije novosintetisanih rutenijum(II)-arenskih kompleksa. Upitanju je serija Ru(II)-arenskih kompleksa sledeih strukturnih formula: [(6-pcimen)Ru(L1–3)Cl2], gde je L1–3: 3-acetilpiridin (1), 4-acetilpiridin (2) i 2-amino-5-hloropiridin (3), kao i [(6-p-cimen)Ru(HL4,5)Cl2], gde HL4 i HL5 odovaraizonikotinskoj kiselini (4) i nikotinskoj kiselini (5) i [(6-p-cimen)Ru(HL6–9)Cl], gdeH2L6–9 predstavlja 2,3-piridindikarboksilnu kiselinu (6), 2,4-piridindikarboksilnukiselinu (7), 2,5-piridindikarboksilnu kiselinu (8) i 2,6- piridindikarboksilnu kiselinu(9), i [(6-p-cimen)RuCl(L11)], gde je HL11 pikolinska kiselina (11). Kompleks (10) jepolazni kompleks [(6-p-cymene)2RuCl2]2 koji je korišen za sinteze navedenihkompleksa u reakciji sa odgovarajuim ligandima. Antiproliferativna aktivnost Ru(II)-arenskih kompleksa je ispitana na: šest tumorskih elijskih linija (HeLa, MDA-MB-361,MDA-MB-453, FemX, B16, LS-174), na dve transformisane endotelijalne linije (EA.hy926, MS1) i na jednoj normalnoj humanoj liniji (MRC-5). Za dalja ispitivanja poreenjapovezanosti strukture i aktivnosti odabrana su dva kompleksa sa monodentatno vezanimpiridinskim ligandom (1 i 3) i dva kompleksa sa bidentano vezanim piridinskimligandom (6 i 7), koji nisu imali znaajnu citotoksinu aktivnost i pikolinatorutenijum(II)-cimenski kompleks (11), kao kompleks sa znaajnom aktivnošu.Potencijal ispitivanih kompleksa da indukuju promene na nivou elijskog ciklusaodreen je korišenjem protonog citometra nakon bojenja tretiranih elija sapropidijum-jodidom. Takoe, korišenjem testa za detekciju rane faze apoptoze,dvokolornim bojenjem elija sa aneksinom i propidijum-jodidom i analize naprotonom citometru ispitan je potencijal kompleksa 11 da indukuje apoptozu.Distribucija rutenijuma(II) u proteinskoj i DNK frakciji HeLa elija tretiranih saispitivanim kompleksima utvrena je korišenjem indukovano kuplovane plazme sa optiko emisionom spektrometrijom (ICP-OES)...
AB  - The aim of this thesis was to investigate antiproliferative and in vitro antimetastaticpotential of series of newly synthesized ruthenium(II)-arene complexes. It is a series ofRu(II)-arene complexes of general formula: [(6-p-cymene)Ru(L1–3)Cl2], where L1–3is 3-acetylpyridine (1), 4-acetylpyridine (2) and 2-amino-5-chloropyridine (3),correspondingly, [(6-p-cymene)Ru(HL4,5)Cl2], where HL4 i HL5 are respectivelyisonicotinic acid (4) and nicotinic acid (5) and [(6-p-cymene)Ru(HL6–9)Cl], whereH2L6–9 represent 2,3-pyridinedicarboxylic acid (6), 2,4-pyridinedicarboxylic acid (7),2,5-pyridinedicarboxylic acid (8) and 2,6- pyridinedicarboxylic acid (9), and [(6-pcymene)RuCl(L11)], where HL11 is picolinic acid (11). Complex [(6-pcymene)2RuCl2]2 (10) was starting complex used for the synthesis of complexes of thisseries with the corresponding ligands. Analysis of cell growth inhibition caused byRu(II)-arene complexes was performed on: six tumor cell lines (HeLa, MDA-MB-361,MDA-MB-453, FemX, B16, LS-174), on two transformed endothelial lines (EA.hy 926,MS1) and on one normal human cell line (MRC-5). For further examination ofcomparison of structure and activity we used two complexes with monodentate bondedpyridine ligand (1 an 3) and two with bidentate bonded pyridine ligand (6 and 7), whichdidn´t have any important cytotoxic activity and picolinate ruthenium(II)-cymenecomplex (11), as complex with important activity. Potential of investigated complexesto induce cell cycle perturbations was determined after staining of treated cells withpropidium iodide (PI) on flow cytometer. As well as determination of induction of early apoptotic changes by complex 11, after two colors staining with Annexin V-FITC andPI and analysis on flow cytometer. Ru(II) distribution among the DNA and proteinfractions in HeLa cells treated with investigated complexes was determined usinginductive coupled plasma with optical emissione spectrometry (ICP-OES). In this studywe evaluated whether DNA-repair-dependent signaling, as a result of interaction withDNA, which includes components of NER or MMR is utilized in cell response to ruthenium(II)-p-cymene complexes, by following expression of ERCC1 (mRNA andprotein level) and MSH2 (protein level) using Quantitative Real-Time PCR (RQ-PCR)and Western blot...
PB  - Универзитет у Београду, Хемијски факултет
T2  - Универзитет у Београду
T1  - Ispitivanje antiproliferativnog i in vitro antimetastatskog potencijala pikolinato rutenijum(II)-cimenskog kompleksa : poređenje sa serijom rutenijum(II)-arenskih kompleksa sa sličnom strukturom
T1  - Investigation of antiproliferative and in vitro antimetastatic potential of picolinate ruthenium(II)-cymene complex : comparison to a series of ruthenium(II)-arene complexes with similar structure
UR  - https://hdl.handle.net/21.15107/rcub_nardus_3462
ER  - 
@phdthesis{
author = "Gligorijević, Nevenka N.",
year = "2012",
abstract = "Cilj ove disertacije bio je ispitivanje potencijala antiproliferativnog i in vitroantimetastatskog dejstva serije novosintetisanih rutenijum(II)-arenskih kompleksa. Upitanju je serija Ru(II)-arenskih kompleksa sledeih strukturnih formula: [(6-pcimen)Ru(L1–3)Cl2], gde je L1–3: 3-acetilpiridin (1), 4-acetilpiridin (2) i 2-amino-5-hloropiridin (3), kao i [(6-p-cimen)Ru(HL4,5)Cl2], gde HL4 i HL5 odovaraizonikotinskoj kiselini (4) i nikotinskoj kiselini (5) i [(6-p-cimen)Ru(HL6–9)Cl], gdeH2L6–9 predstavlja 2,3-piridindikarboksilnu kiselinu (6), 2,4-piridindikarboksilnukiselinu (7), 2,5-piridindikarboksilnu kiselinu (8) i 2,6- piridindikarboksilnu kiselinu(9), i [(6-p-cimen)RuCl(L11)], gde je HL11 pikolinska kiselina (11). Kompleks (10) jepolazni kompleks [(6-p-cymene)2RuCl2]2 koji je korišen za sinteze navedenihkompleksa u reakciji sa odgovarajuim ligandima. Antiproliferativna aktivnost Ru(II)-arenskih kompleksa je ispitana na: šest tumorskih elijskih linija (HeLa, MDA-MB-361,MDA-MB-453, FemX, B16, LS-174), na dve transformisane endotelijalne linije (EA.hy926, MS1) i na jednoj normalnoj humanoj liniji (MRC-5). Za dalja ispitivanja poreenjapovezanosti strukture i aktivnosti odabrana su dva kompleksa sa monodentatno vezanimpiridinskim ligandom (1 i 3) i dva kompleksa sa bidentano vezanim piridinskimligandom (6 i 7), koji nisu imali znaajnu citotoksinu aktivnost i pikolinatorutenijum(II)-cimenski kompleks (11), kao kompleks sa znaajnom aktivnošu.Potencijal ispitivanih kompleksa da indukuju promene na nivou elijskog ciklusaodreen je korišenjem protonog citometra nakon bojenja tretiranih elija sapropidijum-jodidom. Takoe, korišenjem testa za detekciju rane faze apoptoze,dvokolornim bojenjem elija sa aneksinom i propidijum-jodidom i analize naprotonom citometru ispitan je potencijal kompleksa 11 da indukuje apoptozu.Distribucija rutenijuma(II) u proteinskoj i DNK frakciji HeLa elija tretiranih saispitivanim kompleksima utvrena je korišenjem indukovano kuplovane plazme sa optiko emisionom spektrometrijom (ICP-OES)..., The aim of this thesis was to investigate antiproliferative and in vitro antimetastaticpotential of series of newly synthesized ruthenium(II)-arene complexes. It is a series ofRu(II)-arene complexes of general formula: [(6-p-cymene)Ru(L1–3)Cl2], where L1–3is 3-acetylpyridine (1), 4-acetylpyridine (2) and 2-amino-5-chloropyridine (3),correspondingly, [(6-p-cymene)Ru(HL4,5)Cl2], where HL4 i HL5 are respectivelyisonicotinic acid (4) and nicotinic acid (5) and [(6-p-cymene)Ru(HL6–9)Cl], whereH2L6–9 represent 2,3-pyridinedicarboxylic acid (6), 2,4-pyridinedicarboxylic acid (7),2,5-pyridinedicarboxylic acid (8) and 2,6- pyridinedicarboxylic acid (9), and [(6-pcymene)RuCl(L11)], where HL11 is picolinic acid (11). Complex [(6-pcymene)2RuCl2]2 (10) was starting complex used for the synthesis of complexes of thisseries with the corresponding ligands. Analysis of cell growth inhibition caused byRu(II)-arene complexes was performed on: six tumor cell lines (HeLa, MDA-MB-361,MDA-MB-453, FemX, B16, LS-174), on two transformed endothelial lines (EA.hy 926,MS1) and on one normal human cell line (MRC-5). For further examination ofcomparison of structure and activity we used two complexes with monodentate bondedpyridine ligand (1 an 3) and two with bidentate bonded pyridine ligand (6 and 7), whichdidn´t have any important cytotoxic activity and picolinate ruthenium(II)-cymenecomplex (11), as complex with important activity. Potential of investigated complexesto induce cell cycle perturbations was determined after staining of treated cells withpropidium iodide (PI) on flow cytometer. As well as determination of induction of early apoptotic changes by complex 11, after two colors staining with Annexin V-FITC andPI and analysis on flow cytometer. Ru(II) distribution among the DNA and proteinfractions in HeLa cells treated with investigated complexes was determined usinginductive coupled plasma with optical emissione spectrometry (ICP-OES). In this studywe evaluated whether DNA-repair-dependent signaling, as a result of interaction withDNA, which includes components of NER or MMR is utilized in cell response to ruthenium(II)-p-cymene complexes, by following expression of ERCC1 (mRNA andprotein level) and MSH2 (protein level) using Quantitative Real-Time PCR (RQ-PCR)and Western blot...",
publisher = "Универзитет у Београду, Хемијски факултет",
journal = "Универзитет у Београду",
title = "Ispitivanje antiproliferativnog i in vitro antimetastatskog potencijala pikolinato rutenijum(II)-cimenskog kompleksa : poređenje sa serijom rutenijum(II)-arenskih kompleksa sa sličnom strukturom, Investigation of antiproliferative and in vitro antimetastatic potential of picolinate ruthenium(II)-cymene complex : comparison to a series of ruthenium(II)-arene complexes with similar structure",
url = "https://hdl.handle.net/21.15107/rcub_nardus_3462"
}
Gligorijević, N. N.. (2012). Ispitivanje antiproliferativnog i in vitro antimetastatskog potencijala pikolinato rutenijum(II)-cimenskog kompleksa : poređenje sa serijom rutenijum(II)-arenskih kompleksa sa sličnom strukturom. in Универзитет у Београду
Универзитет у Београду, Хемијски факултет..
https://hdl.handle.net/21.15107/rcub_nardus_3462
Gligorijević NN. Ispitivanje antiproliferativnog i in vitro antimetastatskog potencijala pikolinato rutenijum(II)-cimenskog kompleksa : poređenje sa serijom rutenijum(II)-arenskih kompleksa sa sličnom strukturom. in Универзитет у Београду. 2012;.
https://hdl.handle.net/21.15107/rcub_nardus_3462 .
Gligorijević, Nevenka N., "Ispitivanje antiproliferativnog i in vitro antimetastatskog potencijala pikolinato rutenijum(II)-cimenskog kompleksa : poređenje sa serijom rutenijum(II)-arenskih kompleksa sa sličnom strukturom" in Универзитет у Београду (2012),
https://hdl.handle.net/21.15107/rcub_nardus_3462 .